Linked Life Data

9125831

Source:http://linkedlifedata.com/resource/pubmed/id/9125831

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1997-5-21
pubmed:abstractText
Relapse pattern in P. vivax malaria was studied in five villages of Nadiad taluka, Kheda district, Gujarat. P. vivax cases treated with 600 mg chloroquine and in combination with 50 mg pyrimethamine (adult dose) yielded 28.31 and 27.73% relapse rate respectively. While relapse rate of 5.78% was observed with five day course of 75 mg primaquine (15 mg/day) administered as radical treatment. Relapse rate in 5-10 yr of age group was comparatively more than other age groups. There was no noticeable difference in relapse rates among male and female. The short-term relapse with a lag period of 2-3 months was significantly higher in this area. The longest relapse with an interval of 17 months was found in one case treated with chloroquine along with pyrimethamine. However, primaquine regimen prevented consecutive relapses. Primaquine has been found adequate to prevent relapse in more than 90% vivax cases, while efficacy of chloroquine-pyrimethamine and chloroquine alone was almost comparable. A high proportion of relapse may be minimized, if 5-days radical treatment is given at appropriate time.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0367-8326
pubmed:author
pubmed:issnType
Print
pubmed:volume
33
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
173-9
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
pubmed:affiliation
Malaria Research Centre (Field Station), Civil Hospital, Nadiad, India.
pubmed:publicationType
Journal Article